🇸🇬 PAZOPANIB in Singapore

PAZOPANIB (PAZOPANIB) regulatory status in Singapore.

Marketing authorisations

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

PAZOPANIB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PAZOPANIB approved in Singapore?

Yes. HSA has authorised it; HSA has authorised it; HSA has authorised it.

Who is the marketing authorisation holder for PAZOPANIB in Singapore?

Marketing authorisation holder not available in our data.